nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement to Referees
|
|
|
2017 |
|
4 |
p. 231-232 |
artikel |
2 |
Acknowledgement to Referees
|
|
|
2018 |
|
4 |
p. 355-356 |
artikel |
3 |
Acknowledgement to Referees
|
|
|
|
|
4 |
p. 429-431 |
artikel |
4 |
Acknowledgement to Referees
|
|
|
|
|
4 |
p. 555-556 |
artikel |
5 |
A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers
|
Foroutan, Naghmeh |
|
|
|
4 |
p. 437-451 |
artikel |
6 |
A Corticosteroid-Eluting Sinus Implant Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis: A UK-Based Cost-Effectiveness Analysis
|
Javanbakht, Mehdi |
|
|
|
4 |
p. 679-686 |
artikel |
7 |
A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa
|
Makhele, Letlhogonolo |
|
|
|
4 |
p. 631-641 |
artikel |
8 |
A Model-Based Economic Evaluation of Cladribine Versus Alemtuzumab, Ocrelizumab and Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Chile
|
Espinoza, Manuel Antonio |
|
|
|
4 |
p. 635-647 |
artikel |
9 |
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study
|
de Andrés-Nogales, Fernando |
|
|
|
4 |
p. 615-624 |
artikel |
10 |
Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017
|
Usher, Cara |
|
|
|
4 |
p. 583-589 |
artikel |
11 |
An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery
|
Campbell, Julie A. |
|
2017 |
|
4 |
p. 443-458 |
artikel |
12 |
Application of a Mapping Function to Estimate Utilities for Ragweed Allergy Immunotherapy Trials
|
Dick, Katherine |
|
|
|
4 |
p. 649-655 |
artikel |
13 |
A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R
|
Lin, Yi-Shu |
|
|
|
4 |
p. 507-523 |
artikel |
14 |
A Systematic Review of the Health Economics of Pompe Disease
|
Schoser, Benedikt |
|
|
|
4 |
p. 479-493 |
artikel |
15 |
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
|
Stainthorpe, Angela |
|
|
|
4 |
p. 563-574 |
artikel |
16 |
Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
|
Fleeman, Nigel |
|
|
|
4 |
p. 453-461 |
artikel |
17 |
Check Your Checklist: The Danger of Over- and Underestimating the Quality of Economic Evaluations
|
Frederix, Geert W. J. |
|
|
|
4 |
p. 433-435 |
artikel |
18 |
Choosing Between Unicompartmental and Total Knee Replacement: What Can Economic Evaluations Tell Us? A Systematic Review
|
Burn, Edward |
|
2017 |
|
4 |
p. 241-253 |
artikel |
19 |
Correction to: A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa
|
Makhele, Letlhogonolo |
|
|
|
4 |
p. 647 |
artikel |
20 |
Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries
|
Fontrier, Anna-Maria |
|
|
|
4 |
p. 629 |
artikel |
21 |
Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial
|
Tran, Anh Dam |
|
|
|
4 |
p. 587-594 |
artikel |
22 |
Cost Analysis of the Automated Examination of Urine with the Sysmex UN-Series™ in a Spanish Population
|
Herráez Carrera, Óscar |
|
|
|
4 |
p. 605-613 |
artikel |
23 |
Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews
|
Monga, Neerav |
|
|
|
4 |
p. 575-591 |
artikel |
24 |
Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UK
|
Telford, Claire |
|
|
|
4 |
p. 559-570 |
artikel |
25 |
Cost-Effectiveness Analysis of Intravascular Targeted Temperature Management after Cardiac Arrest in England
|
Javanbakht, Mehdi |
|
|
|
4 |
p. 549-562 |
artikel |
26 |
Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)
|
Garay, Osvaldo Ulises |
|
|
|
4 |
p. 505-515 |
artikel |
27 |
Cost-Effectiveness Analysis of rFVIIIFc Versus Contemporary rFVIII Treatments for Patients with Severe Hemophilia A Without Inhibitors in the United States
|
Bullement, Ash |
|
|
|
4 |
p. 625-633 |
artikel |
28 |
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK
|
Schweikert, Bernd |
|
|
|
4 |
p. 635-648 |
artikel |
29 |
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
|
Djatche, Laurence M. |
|
2018 |
|
4 |
p. 371-380 |
artikel |
30 |
Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France
|
Caillon, Megane |
|
|
|
4 |
p. 639-653 |
artikel |
31 |
Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK
|
Russell-Smith, T. Alexander |
|
|
|
4 |
p. 677-691 |
artikel |
32 |
Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland
|
Çakar, Esra |
|
|
|
4 |
p. 567-577 |
artikel |
33 |
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
|
Johansen, Pierre |
|
|
|
4 |
p. 537-550 |
artikel |
34 |
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare Sector Setting
|
Raunbak, Sabine Michelsen |
|
|
|
4 |
p. 483-494 |
artikel |
35 |
Cost-Effectiveness of Peer-Educator–Delivered Lifestyle Modification for Type 2 Diabetes Prevention in a Young Healthy Population in Sri Lanka: A Trial-Based Economic Evaluation and Economic Model
|
Shearer, James |
|
|
|
4 |
p. 693-700 |
artikel |
36 |
Cost-Effectiveness of Semaglutide vs. Empagliflozin, Canagliflozin, and Sitagliptin for Treatment of Patients with Type 2 Diabetes in Denmark: A Decision-Analytic Modelling Study
|
Pulleyblank, Ryan |
|
|
|
4 |
p. 579-591 |
artikel |
37 |
Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in Tanzania
|
Shah, Hiral Anil |
|
|
|
4 |
p. 537-552 |
artikel |
38 |
Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada
|
Fenu, Elisabetta |
|
|
|
4 |
p. 519-537 |
artikel |
39 |
Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Perspective
|
Qiao, Nan |
|
|
|
4 |
p. 765-778 |
artikel |
40 |
Costs and Effects of Implementing Digital Tomosynthesis in a Population-Based Breast Cancer Screening Program: Predictions Using Results from the To-Be Trial in Norway
|
Moger, Tron Anders |
|
|
|
4 |
p. 495-507 |
artikel |
41 |
Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia
|
Belay, Yared Belete |
|
|
|
4 |
p. 655-664 |
artikel |
42 |
Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review
|
Zelei, Tamás |
|
|
|
4 |
p. 605-612 |
artikel |
43 |
Dealing with Time Estimates in Hospital Cost Accounting: Integrating Fuzzy Logic into Time-Driven Activity-Based Costing
|
Koster, Fiona |
|
|
|
4 |
p. 593-603 |
artikel |
44 |
Development of a Procedure for the Government Provision of Bone-Anchored Prosthesis Using Osseointegration in Australia
|
Frossard, Laurent |
|
2017 |
|
4 |
p. 301-314 |
artikel |
45 |
Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) Instrument
|
Reaney, Matthew |
|
|
|
4 |
p. 563-574 |
artikel |
46 |
Differences in Breast Cancer Costs by Cancer Stage and Biomarker Subtype in New Zealand
|
Lao, Chunhuan |
|
|
|
4 |
p. 539-548 |
artikel |
47 |
Direct and Indirect Costs of Non-surgical Treatment for Acute Tonsillitis in Children in Southeast Nigeria
|
Ughasoro, Maduka Donatus |
|
|
|
4 |
p. 755-764 |
artikel |
48 |
Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain
|
Gil de Miguel, Ángel |
|
|
|
4 |
p. 509-518 |
artikel |
49 |
Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review
|
Pergola, Pablo E. |
|
|
|
4 |
p. 463-478 |
artikel |
50 |
Economic Burden of the Out-of-Pocket Expenses for People with Multiple Sclerosis in France
|
Heinzlef, Olivier |
|
|
|
4 |
p. 593-603 |
artikel |
51 |
Economic Evaluation of Fulvestrant 500 mg Compared to Generic Aromatase Inhibitors in Patients with Advanced Breast Cancer in Sweden
|
Sabale, Ugne |
|
2017 |
|
4 |
p. 279-290 |
artikel |
52 |
Economic Evaluation of Transperineal versus Transrectal Devices for Local Anaesthetic Prostate Biopsies
|
Wilson, Edward C. F. |
|
|
|
4 |
p. 737-753 |
artikel |
53 |
Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis
|
Afentou, Nafsika |
|
|
|
4 |
p. 605-617 |
artikel |
54 |
Effect of Perioperative Oral Vitamin C Supplementation on In-Hospital Postoperative Medication Costs for Cardiac Surgery Patients: A Prospective, Single-Centre, Randomised Clinical Trial
|
Heerman, Jan |
|
|
|
4 |
p. 655-663 |
artikel |
55 |
Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity
|
Mavrodi, A. |
|
2017 |
|
4 |
p. 291-300 |
artikel |
56 |
Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis
|
Bazarbashi, Shouki |
|
|
|
4 |
p. 625-633 |
artikel |
57 |
Estimation of Health-Related Utilities for 177Lu-DOTATATE in GEP-NET Patients Using Utilities Mapped from EORTC QLQ-C30 to EQ-5D-3L and QLU-C10D Utilities
|
Soare, Ioana-Alexandra |
|
|
|
4 |
p. 715-725 |
artikel |
58 |
Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
|
Kruger, Eliza |
|
|
|
4 |
p. 627-638 |
artikel |
59 |
Estimation of the Incremental Cumulative Cost of HIV Compared with a Non-HIV Population
|
Cohen, Joshua P. |
|
|
|
4 |
p. 687-696 |
artikel |
60 |
Evidence-Based Medicine and Healthcare Quality in the Context of Information Failure: The Case of the UK Fertility Sector
|
Zhu, Minyan |
|
|
|
4 |
p. 561-576 |
artikel |
61 |
Feasibility of Deriving Health State Utilities in Mycosis Fungoides Cutaneous T-Cell Lymphoma Using Mapping Algorithms
|
Meregaglia, Michela |
|
|
|
4 |
p. 595-603 |
artikel |
62 |
Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls
|
Kingdon, Caroline C. |
|
2018 |
|
4 |
p. 381-392 |
artikel |
63 |
gammaCore for Cluster Headaches: A NICE Medical Technologies Guidance
|
O’Connell, Susan |
|
|
|
4 |
p. 577-586 |
artikel |
64 |
Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014
|
Nathanson, David |
|
2017 |
|
4 |
p. 393-402 |
artikel |
65 |
Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD Countries
|
Mills, Mackenzie |
|
|
|
4 |
p. 553-565 |
artikel |
66 |
Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
|
Kocaata, Zeki |
|
|
|
4 |
p. 619-628 |
artikel |
67 |
Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis
|
Vanderpoel, Julie |
|
|
|
4 |
p. 617-626 |
artikel |
68 |
Hospital Costs of Extracorporeal Membrane Oxygenation in Adults: A Systematic Review
|
Oude Lansink-Hartgring, Annemieke |
|
|
|
4 |
p. 613-623 |
artikel |
69 |
How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton
|
Roope, Laurence S. J. |
|
|
|
4 |
p. 557-561 |
artikel |
70 |
Impact of Including Carer Information in Time Trade-Off Tasks: Results from a Pilot Study
|
Mott, David J. |
|
|
|
4 |
p. 665-675 |
artikel |
71 |
Including Future Consumption and Production in Economic Evaluation of Interventions that Save Life-Years: Commentary
|
Nord, Erik |
|
2018 |
|
4 |
p. 357-358 |
artikel |
72 |
Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses
|
Nymark, Liv Solvår |
|
|
|
4 |
p. 587-603 |
artikel |
73 |
Indonesian Social Health Insurance Sample Data are Now Available and Accessible for Research
|
Fuad, Anis |
|
|
|
4 |
p. 643-645 |
artikel |
74 |
Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study
|
Khan, Iftekhar |
|
|
|
4 |
p. 697-710 |
artikel |
75 |
Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER+ Breast Cancer: A Systematic Review
|
Xiao, Hong |
|
2018 |
|
4 |
p. 359-369 |
artikel |
76 |
Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial
|
Reaney, Matthew |
|
|
|
4 |
p. 575-586 |
artikel |
77 |
Long-Term Inpatient Hospital Utilisation and Costs (2007–2008 to 2015–2016) for Publicly Waitlisted Bariatric Surgery Patients in an Australian Public Hospital System Based on Australia’s Activity-Based Funding Model
|
Campbell, Julie A. |
|
|
|
4 |
p. 599-618 |
artikel |
78 |
Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis
|
Baldwin, Zachary |
|
|
|
4 |
p. 469-481 |
artikel |
79 |
Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)
|
Masucci, Lisa |
|
2017 |
|
4 |
p. 255-263 |
artikel |
80 |
National Health Insurance Databases in Indonesia, Vietnam and the Philippines
|
Ng, Junice Yi Siu |
|
|
|
4 |
p. 517-526 |
artikel |
81 |
Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making
|
Gordon, Jason |
|
|
|
4 |
p. 701-713 |
artikel |
82 |
Observational Cost-Effectiveness Analysis Using Routine Data: Admission and Discharge Care Bundles for Patients with Chronic Obstructive Pulmonary Disease
|
Dixon, Padraig |
|
|
|
4 |
p. 657-667 |
artikel |
83 |
Out-of-Pocket Household Expenditures on Medical Injections in Cambodia
|
Ozawa, Sachiko |
|
2018 |
|
4 |
p. 415-421 |
artikel |
84 |
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
|
Bresnahan, Rebecca |
|
|
|
4 |
p. 525-536 |
artikel |
85 |
Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial
|
Pirhonen, Laura |
|
|
|
4 |
p. 495-504 |
artikel |
86 |
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
|
Wahono, Cesarius Singgih |
|
|
|
4 |
p. 605-615 |
artikel |
87 |
Smart Pump–Electronic Health Record (EHR) Interoperability with Auto-Documentation is Associated with Increased Submission of Infusion-Therapy Billing Claims at a Community Hospital
|
Suess, Tina M. |
|
|
|
4 |
p. 619-629 |
artikel |
88 |
Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan
|
Corelli, Robin L. |
|
|
|
4 |
p. 649-653 |
artikel |
89 |
Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values
|
Round, Jeff |
|
2017 |
|
4 |
p. 233-239 |
artikel |
90 |
Systematic Review and Cost-Consequence Analysis of Ambu aScope 5 Broncho Compared with Reusable Flexible Bronchoscopes: Insights from Two US University Hospitals and an Academic Institution
|
Kristensen, Anders E. |
|
|
|
4 |
p. 665-678 |
artikel |
91 |
The Budget Impact of Introducing Tildrakizumab to a United States Health Plan for Managing Moderate-to-Severe Plaque Psoriasis
|
Carrico, Justin |
|
|
|
4 |
p. 669-677 |
artikel |
92 |
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study
|
Jommi, Claudio |
|
2017 |
|
4 |
p. 459-467 |
artikel |
93 |
The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US
|
Chatterjee, Satabdi |
|
|
|
4 |
p. 727-736 |
artikel |
94 |
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
|
Akpinar, Ilke |
|
|
|
4 |
p. 591-597 |
artikel |
95 |
The Healthcare Cost Burden of Acute Myocardial Infarction in Alberta, Canada
|
Tran, Dat T. |
|
2017 |
|
4 |
p. 433-442 |
artikel |
96 |
Use of Initial Noninvasive Cardiac Testing and Association with Downstream Healthcare Resource: A Retrospective Review of Resources Used Across a 12-Month Window for Probable Type I Myocardial Infarction Patients
|
Villines, Dana |
|
|
|
4 |
p. 527-535 |
artikel |
97 |
Using a Discrete-Choice Experiment to Estimate the Preferences of Clinical Practitioners for a Novel Non-invasive Device for Diagnosis of Peripheral Arterial Disease in Primary Care
|
Oluboyede, Yemi |
|
|
|
4 |
p. 571-581 |
artikel |
98 |
Using Time Trade-Off Methods to Elicit Short-Term Utilities Associated with Treatments for Bulbar Urethral Stricture
|
Shen, Jing |
|
|
|
4 |
p. 551-558 |
artikel |
99 |
Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications
|
Jakupi, Arianit |
|
2018 |
|
4 |
p. 423-432 |
artikel |
100 |
Utilization of Intergovernmental Funds to Implement Maternal and Child Health Plans of a Multi-Strategy Community Intervention in Haryana, North India: A Retrospective Assessment
|
Gupta, Madhu |
|
2017 |
|
4 |
p. 265-278 |
artikel |
101 |
Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease
|
Lomas, James |
|
2018 |
|
4 |
p. 403-413 |
artikel |